Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

[1]  H. Jasper,et al.  The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology. , 1999, Electroencephalography and clinical neurophysiology. Supplement.

[2]  P. Maruff,et al.  Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children , 1999, Psychological Medicine.

[3]  S. Stahl,et al.  Stahl's essential psychopharmacology : neuroscientific basis and practical application , 2008 .

[4]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[5]  A. Arnsten,et al.  Stimulants: Therapeutic Actions in ADHD , 2006, Neuropsychopharmacology.

[6]  Nikos Makris,et al.  Towards Conceptualizing a Neural Systems-Based Anatomy of Attention-Deficit/Hyperactivity Disorder , 2009, Developmental Neuroscience.

[7]  C. Berridge,et al.  Psychostimulants as Cognitive Enhancers: The Prefrontal Cortex, Catecholamines, and Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.

[8]  Andreas Mühlberger,et al.  Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD. , 2011, Journal of psychiatric research.

[9]  Ata Akın,et al.  Association Among SNAP-25 Gene DdeI and MnlI Polymorphisms and Hemodynamic Changes During Methylphenidate Use , 2011, Journal of attention disorders.

[10]  Natalia del Campo,et al.  The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder , 2011, Biological Psychiatry.

[11]  P. Hazell,et al.  Core ADHD Symptom Improvement With Atomoxetine Versus Methylphenidate , 2011, Journal of attention disorders.

[12]  E. Watanabe,et al.  Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS , 2012, Clinical Neurophysiology.

[13]  Haruka Dan,et al.  Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: An fNIRS study☆ , 2012, NeuroImage: Clinical.

[14]  N. Skokauskas,et al.  Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects , 2012, Acta psychiatrica Scandinavica.

[15]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[16]  Eiju Watanabe,et al.  Neuropharmacological effect of atomoxetine on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy , 2014, Neurophotonics.

[17]  Mizuki Asano,et al.  Effects of methylphenidate in children with attention deficit hyperactivity disorder: a near-infrared spectroscopy study with CANTAB® , 2014, Child and Adolescent Psychiatry and Mental Health.

[18]  Haruka Dan,et al.  Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study , 2014, NeuroImage: Clinical.

[19]  Martin Wolf,et al.  A review on continuous wave functional near-infrared spectroscopy and imaging instrumentation and methodology , 2014, NeuroImage.

[20]  Eiju Watanabe,et al.  Neuropharmacological effect of methylphenidate on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy , 2014, Neurophotonics.

[21]  T. Hara,et al.  Altered strategy in short-term memory for pictures in children with attention-deficit/hyperactivity disorder: A near-infrared spectroscopy study , 2014, Psychiatry Research: Neuroimaging.

[22]  H. Yamasue,et al.  Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial , 2015, Neuropsychopharmacology.

[23]  Hideki Negoro,et al.  Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention‐deficit/hyperactivity disorder as measured by near‐infrared spectroscopy , 2015, Psychiatry and clinical neurosciences.

[24]  Masanaga Ikegami,et al.  Improved prefrontal activity in AD/HD children treated with atomoxetine: A NIRS study , 2015, Brain and Development.

[25]  Jan K. Buitelaar,et al.  Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.

[26]  T. Kishimoto,et al.  Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy , 2017, Child and Adolescent Psychiatry and Mental Health.